Cargando…
Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016
IMPORTANCE: The federal 340B program lowers the acquisition cost of prescription drugs and places no limits on what hospitals charge payers. Congress established the program to allow 340B profits (the difference between payments and acquisition costs) to subsidize other safety-net services. Little i...
Autores principales: | Conti, Rena M., Nikpay, Sayeh S., Buntin, Melinda B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824218/ https://www.ncbi.nlm.nih.gov/pubmed/31664442 http://dx.doi.org/10.1001/jamanetworkopen.2019.14141 |
Ejemplares similares
-
Trends in Proportion of Medicare Part D Claims Subject to 340B Discounts, 2013-2020
por: Dickson, Sean, et al.
Publicado: (2023) -
Association Between New 340B Program Participation and Commercial Insurance Spending on Outpatient Biologic Oncology Drugs
por: Chang, Jessica, et al.
Publicado: (2023) -
Breadth and Exclusivity of Hospital and Physician Networks in US Insurance Markets
por: Graves, John A., et al.
Publicado: (2020) -
Geographic Variation in Hospital-Based Physician Participation in Insurance Networks
por: Nikpay, Sayeh, et al.
Publicado: (2022) -
Trends in 340B Drug Pricing Program Contract Growth Among Retail Pharmacies From 2009 to 2022
por: Nikpay, Sayeh, et al.
Publicado: (2023)